Tempus AI Revenue 2023-2025 | TEM
Tempus AI annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tempus AI revenue for the quarter ending March 31, 2025 was $0.256B, a 75.38% increase year-over-year.
- Tempus AI revenue for the twelve months ending March 31, 2025 was $0.803B, a 42.93% increase year-over-year.
- Tempus AI annual revenue for 2024 was $0.693B, a 30.38% increase from 2023.
- Tempus AI annual revenue for 2023 was $0.532B, a 65.85% increase from 2022.
- Tempus AI annual revenue for 2022 was $0.321B, a 0% decline from .
| Tempus AI Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $693 |
| 2023 | $532 |
| 2022 | $321 |
| Tempus AI Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $256 |
| 2024-12-31 | $201 |
| 2024-09-30 | $181 |
| 2024-06-30 | $166 |
| 2024-03-31 | $146 |
| 2023-12-31 | $148 |
| 2023-09-30 | $136 |
| 2023-06-30 | $132 |
| 2023-03-31 | $116 |
| 2022-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.733B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.813B | 60.83 |
| Hims & Hers Health (HIMS) | United States | $13.134B | 136.46 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| IRhythm Technologies (IRTC) | United States | $4.377B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.856B | 60.24 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.803B | 0.00 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Azenta (AZTA) | United States | $1.562B | 72.62 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Omnicell (OMCL) | United States | $1.358B | 23.97 |
| Evolent Health (EVH) | United States | $1.133B | 96.50 |
| Claritev (CTEV) | United States | $0.664B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Standard BioTools (LAB) | United States | $0.539B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.428B | 128.00 |
| TruBridge (TBRG) | United States | $0.347B | 771.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.244B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| CapsoVision (CV) | United States | $0.202B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.120B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |